Steris

STE

Market cap $26.1B

Steris (STE) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Examine the evolution of Steris' (STE) overseas revenue trends and their effects on Wall Street's forecasts and the stock's prospects.

STERIS plc ( STE ) Q2 2026 Earnings Call November 6, 2025 9:00 AM EST Company Participants Julie Winter - Vice President of Investor Relations & Corporate Communications Karen Burton - Senior VP, CFO & Chief Accounting Officer Daniel Carestio - President, CEO & Director Conference Call Participants Brett Fishbin - KeyBanc Capital Markets Inc., Research Division Patrick Wood - Morgan Stanley, Research Division Jason Bednar - Piper Sandler & Co., Research Division Michael Matson - Needham & Company, LLC, Research Division Michael Polark - Wolfe Research, LLC Presentation Operator Hello, and thank you for standing by. My name is Bella, and I will be your conference operator today.

STERIS posts strong Q2 results with earnings and revenue beats, margin expansion, and a raised 2026 EPS outlook.

Although the revenue and EPS for Steris (STE) give a sense of how its business performed in the quarter ended September 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Steris (STE) came out with quarterly earnings of $2.47 per share, beating the Zacks Consensus Estimate of $2.38 per share. This compares to earnings of $2.14 per share a year ago.

Total revenue from continuing operations increased 10%; constant currency organic revenue grew 9% As reported EPS from continuing operations increased to $1.94; adjusted EPS increased to $2.47 Fiscal 2026 constant currency organic revenue, EPS and free cash flow outlook increased DUBLIN, IRELAND , Nov. 05, 2025 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2026 second quarter ended September 30, 2025. Total revenue from continuing operations for the second quarter of fiscal 2026 increased 10% to $1.5 billion compared with $1.3 billion in the second quarter of fiscal 2025.

Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Steris (STE), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended September 2025.

DUBLIN, IRELAND, Oct. 29, 2025 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that the Company will distribute a quarterly dividend of $0.63 per share. The dividend is payable on December 18, 2025, to shareholders of record at the close of business on November 18, 2025.

STE is set to post fiscal Q2 results on Nov. 6, with estimates pointing to solid revenue and earnings growth across key segments.